Your browser doesn't support javascript.
loading
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience.
Rossi, Sabrina; Finocchiaro, Giovanna; Toschi, Luca; Santoro, Armando.
  • Rossi S; Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano (MI), Italy.
  • Finocchiaro G; Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano (MI), Italy.
  • Toschi L; Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano (MI), Italy.
  • Santoro A; Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano (MI), Italy.
Immunotherapy ; 11(11): 945-952, 2019 08.
Article en En | MEDLINE | ID: mdl-31199183

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carcinoma de Pulmón de Células no Pequeñas / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carcinoma de Pulmón de Células no Pequeñas / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article